References
- Cooper LJN, Ausubel L, Gutierrez M, et al. Manufacturing of gene modified cytotoxic T lymphocytes for autologous cellular therapy for lymphoma. Cytotherapy 2006; 8: 105–117
- Wu J, Ernstoff MS, Hill JM, et al. Ex vivo expansion of non-MHC-restricted cytotoxic effector cells as adoptive immunotherapy for meyloma. Cytotherapy 2006; 8: 141–8
- Watanabe N, Narita M, Yokoyama A, et al. Type I IFN-mediated enhancement of anti-leukemic cytotoxicity of γδ T cells expanded from peripheral blood cells by stimulation with zoledronate. Cytotherapy 2006; 8: 118–129
- Lamb LS, Jr, Lopez RD. Gammadelta T cells: a new frontier for immunotherapy?. Biol Blood Marrow Transplant 2005; 11: 161–8